CAMP4 Ebitda from 2010 to 2025

CAMP Stock  USD 5.00  0.49  8.93%   
CAMP4 THERAPEUTICS EBITDA yearly trend continues to be relatively stable with very little volatility. EBITDA is likely to grow to about -7.5 M this year. During the period from 2010 to 2025, CAMP4 THERAPEUTICS EBITDA destribution of quarterly values had r-value of (0.81) from its regression line and median of  18,133,000. View All Fundamentals
 
EBITDA  
First Reported
2010-12-31
Previous Quarter
-7.8 M
Current Value
-7.5 M
Quarterly Volatility
10.9 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CAMP4 THERAPEUTICS financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CAMP4 THERAPEUTICS's main balance sheet or income statement drivers, such as Depreciation And Amortization of 17.8 M, Interest Expense of 8.3 M or Selling General Administrative of 36.9 M, as well as many indicators such as Price To Sales Ratio of 1.26, Ptb Ratio of 70.11 or Capex To Depreciation of 0.84. CAMP4 financial statements analysis is a perfect complement when working with CAMP4 THERAPEUTICS Valuation or Volatility modules.
  
Check out the analysis of CAMP4 THERAPEUTICS Correlation against competitors.

Latest CAMP4 THERAPEUTICS's Ebitda Growth Pattern

Below is the plot of the Ebitda of CAMP4 THERAPEUTICS PORATION over the last few years. It is CAMP4 THERAPEUTICS's EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CAMP4 THERAPEUTICS's overall financial position and show how it may be relating to other accounts over time.
Ebitda10 Years Trend
Slightly volatile
   Ebitda   
       Timeline  

CAMP4 Ebitda Regression Statistics

Arithmetic Mean11,450,228
Coefficient Of Variation94.83
Mean Deviation9,188,812
Median18,133,000
Standard Deviation10,858,453
Sample Variance117.9T
Range26.9M
R-Value(0.81)
Mean Square Error44T
R-Squared0.65
Significance0.0002
Slope(1,841,482)
Total Sum of Squares1768.6T

CAMP4 Ebitda History

2025-7.5 M
2024-7.8 M
2023-8.7 M
2022276 K
20217.5 M

About CAMP4 THERAPEUTICS Financial Statements

CAMP4 THERAPEUTICS shareholders use historical fundamental indicators, such as Ebitda, to determine how well the company is positioned to perform in the future. Although CAMP4 THERAPEUTICS investors may analyze each financial statement separately, they are all interrelated. The changes in CAMP4 THERAPEUTICS's assets and liabilities, for example, are also reflected in the revenues and expenses on on CAMP4 THERAPEUTICS's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
EBITDA-7.8 M-7.5 M

Additional Tools for CAMP4 Stock Analysis

When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.